University of Helsinki
Helsinkihelsinki.fi
Overview
University of Helsinki is the venture investment arm of the university, focusing on pre-seed and seed stage investments in research-based spinouts and startups with a clear connection to the institution. Its technology transfer office, Helsinki Innovation Services (HIS), manages the commercialization pipeline for these ventures.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Avenue Biosciences | Jan 2026 | Seed | Co-investor |
| Perfat Technologies | Sep 2025 | Series A | Co-investor |
| Avenue Biosciences | Jan 2024 | Seed | Co-investor |
| GlucoModicum | Apr 2018 | Pre Seed | Co-investor |
| Acouspin | - | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
